These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19098163)

  • 1. Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice.
    Chen R; Furman CA; Zhang M; Kim MN; Gereau RW; Leitges M; Gnegy ME
    J Pharmacol Exp Ther; 2009 Mar; 328(3):912-20. PubMed ID: 19098163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.
    Chen R; Daining CP; Sun H; Fraser R; Stokes SL; Leitges M; Gnegy ME
    J Neurochem; 2013 Jun; 125(5):663-72. PubMed ID: 23458603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKCbeta co-localizes with the dopamine transporter in mesencephalic neurons.
    O'Malley HA; Park Y; Isom LL; Gnegy ME
    Neurosci Lett; 2010 Aug; 480(1):40-3. PubMed ID: 20641161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta.
    Johnson LA; Guptaroy B; Lund D; Shamban S; Gnegy ME
    J Biol Chem; 2005 Mar; 280(12):10914-9. PubMed ID: 15647254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.
    Hong WC; Amara SG
    FASEB J; 2013 Aug; 27(8):2995-3007. PubMed ID: 23612789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy.
    Furman CA; Chen R; Guptaroy B; Zhang M; Holz RW; Gnegy M
    J Neurosci; 2009 Mar; 29(10):3328-36. PubMed ID: 19279270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKCβ Inhibitors Attenuate Amphetamine-Stimulated Dopamine Efflux.
    Zestos AG; Mikelman SR; Kennedy RT; Gnegy ME
    ACS Chem Neurosci; 2016 Jun; 7(6):757-66. PubMed ID: 26996926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.
    Mannangatti P; Ragu Varman D; Ramamoorthy S; Jayanthi LD
    Pharmacology; 2021; 106(11-12):597-605. PubMed ID: 34515205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.
    Boudanova E; Navaroli DM; Melikian HE
    Neuropharmacology; 2008 Mar; 54(3):605-12. PubMed ID: 18164041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
    Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo.
    Vecchio LM; Bermejo MK; Beerepoot P; Ramsey AJ; Salahpour A
    Mol Cell Neurosci; 2014 Jul; 61():123-32. PubMed ID: 24886986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.
    Challasivakanaka S; Zhen J; Smith ME; Reith MEA; Foster JD; Vaughan RA
    J Biol Chem; 2017 Nov; 292(46):19066-19075. PubMed ID: 28939767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux.
    Wang Q; Bubula N; Brown J; Wang Y; Kondev V; Vezina P
    Neurosci Lett; 2016 May; 622():78-82. PubMed ID: 27113203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Region-Specific Trafficking of the Dopamine Transporter.
    Block ER; Nuttle J; Balcita-Pedicino JJ; Caltagarone J; Watkins SC; Sesack SR; Sorkin A
    J Neurosci; 2015 Sep; 35(37):12845-58. PubMed ID: 26377471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein kinase Cβ-selective inhibitor, enzastaurin, attenuates amphetamine-stimulated locomotor activity and self-administration behaviors in rats.
    Altshuler RD; Carpenter CA; Franke TJ; Gnegy ME; Jutkiewicz EM
    Psychopharmacology (Berl); 2019 Nov; 236(11):3231-3242. PubMed ID: 31134292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
    J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine Dysregulation and Altered Responses to Drugs Affecting Dopaminergic Transmission in a New Dopamine Transporter Knockout (DAT-KO) Rat Model.
    Lloyd JT; Yee AG; Kalligappa PK; Jabed A; Cheung PY; Todd KL; Karunasinghe RN; Vlajkovic SM; Freestone PS; Lipski J
    Neuroscience; 2022 May; 491():43-64. PubMed ID: 35331847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter.
    Briegleb SK; Gulley JM; Hoover BR; Zahniser NR
    Neuropsychopharmacology; 2004 Dec; 29(12):2168-79. PubMed ID: 15292903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome.
    Steinkellner T; Yang JW; Montgomery TR; Chen WQ; Winkler MT; Sucic S; Lubec G; Freissmuth M; Elgersma Y; Sitte HH; Kudlacek O
    J Biol Chem; 2012 Aug; 287(35):29627-35. PubMed ID: 22778257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.